Buchang Pharma: Luzhou Buchang Completes Capital Increase Registration, Company Holds 92.3641% Stake

36Kr learned from an announcement by Buchang Pharma that its controlled subsidiary, Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd., had planned a capital increase to introduce external investors, with the company waiving its preemptive subscription right and assuming a repurchase obligation. Recently, Luzhou Buchang completed the business registration changes for the capital increase and obtained a renewed business license issued by the Luxian Market Supervision Administration, with registered capital of RMB 466,631,579. Following the change, the company holds a 92.3641% equity stake in Luzhou Buchang.